• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HALYARD - IRVINE SURGPN,400X2-14,CB SAF,-,OQ,5; REGIONAL ANESTHESIA PUMP KITS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HALYARD - IRVINE SURGPN,400X2-14,CB SAF,-,OQ,5; REGIONAL ANESTHESIA PUMP KITS Back to Search Results
Model Number CB004
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Reaction (2414)
Event Date 11/22/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The complaint product is reported to be available, but has not yet been received by the manufacturer.The device history record for the lot number, 0300050312, involved in this complaint was reviewed and the material was produced according to the manufacturing procedures and met the quality requirements.Halyard health has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the halyard health complaint database and identified as (b)(4).Device not returned.
 
Event Description
Fill volume: 500 ml, flow rate: 4, 8, 4 ml/hr, procedure: rotator cuff repair, right, cathplace: unknown.Rate was set at 4ml/hr since surgery.9-10pm on (b)(6) turned up to 8; 10pm down to 4.It was reported that a male patient's pump was set at a rate of 4ml/hr since the surgery.On (b)(6) 2016 at 9-10 pm, the rate was turned up to 8 ml/hr, and turned back down to 4 ml/hr at 10 pm.On (b)(6) 2016 the patient reported having ringing in the ears during use of the pump.The patient woke up at 2:30 am on (b)(6) 2016 with ringing in the ears.The patient was instructed to turn off the pump at 3:00 am by the hotline nurse.The patient woke up at 6:00 am and the ringing was gone.The anesthesiologist called the patient back at 7:30 am to instruct the patient to turn the pump on again and to set at 4 ml/hr.At 12:30 pm the patient felt ringing in the ears again.The anesthesiologist told the patient to resume infusion once the ringing goes away.No additional information was provided.
 
Manufacturer Narrative
The pump was returned partially full.The pinch clamp was opened and the pump infused at all selectable flow rates.The tubing was cut below the blue connector to drain the medication.A male and female luer were used with cyclohexanone to bond the tubing back together.The pump was refilled to nominal volume with 400ml of 0.9% saline using a baxa repeater pump.Flow accuracy testing was performed with the saf (select-a-flow) set to 14ml/hr.After 21.5 hours of testing, the pump yielded a flow rate of 2.53ml/hr which is within specifications with a +/- 20% tolerance.Pressure pot was performed on the selected-a-flow unit flow rates 2ml/hr, 4ml/hr, 8ml/hr and 14ml/hr without the filter.The saf unit was detached from the pump.The saf unit was connected to a pressure gauge.The average bladder pressure used was 8.16psi.No infusion was seen at the distal luer.The filter was removed and then infusion was found at all selectable rates.The saf flow rate 2ml/hr yielded a flow rate of 1.71ml/hr, which is within specifications with a +/-20% tolerance.Flow rate 4ml/hr yielded a flow rate of 3.98ml/hr which is within specifications with a +/- 20% tolerance.Flow rate 8ml/hr yielded a flow rate of 7.13ml/hr which is within specifications with a +/- 20% tolerance.Flow rate 14ml/hr yielded a flow rate of 12.95ml/hr which is within specifications with a +/- 20% tolerance.The evaluation summary concluded that a fast flow was not observed.During the flow accuracy test, the pump had a flow rate that was below specification with a +/-20% tolerance.During pressure pot testing the saf would not initially infuse at any rate.After removing the filter flow was observed at each rate and the pressure pot testing met specifications at each of the selected rates when using the average bladder pressure.It was not able to be determined why the filter was preventing flow.The pump had a flow rate that was below specification with a +/-20% tolerance.During pressure pot testing the saf would not initially infuse at any rate.After removing the filter flow was observed at each rate and the pressure pot testing met specifications at each of the selected rates when using the average bladder pressure.It was not able to be determined why the filter was preventing flow.Root cause could not be determined.Halyard health has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the halyard health complaint database and identified as complaint (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGPN,400X2-14,CB SAF,-,OQ,5
Type of Device
REGIONAL ANESTHESIA PUMP KITS
Manufacturer (Section D)
HALYARD - IRVINE
43 discovery
suite 100
irvine CA 92618
Manufacturer (Section G)
AVENT S. DE R.L. DE C.V.
ave noruega edificio d-1b
fraccionamiento rubio
tijuana, b.c.
Manufacturer Contact
lisa clark
5405 windward parkway
alpharetta, GA 30004
4704485444
MDR Report Key6150627
MDR Text Key62127370
Report Number2026095-2016-00218
Device Sequence Number1
Product Code MEB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PUNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/31/2017
Device Model NumberCB004
Device Catalogue Number101347202
Device Lot Number0300050312
Other Device ID Number30680651134722
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/22/2016
Initial Date FDA Received12/07/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/02/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/06/2016
Type of Device Usage N
Patient Sequence Number1
Treatment
ROPIVACAINE 0.2% 500ML
Patient Age67 YR
Patient Weight91
-
-